Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Number of Participants with treatment related adverse events as defined by CTCAE 5.0 Measure: Maternal exposure to RLYB212 as measured in serum. After: Measure: Number of Participants With Treatment Related Adverse Events as Defined by CTCAE 5.0 Measure: Maternal Exposure to RLYB212 as Measured in Serum.